Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 287
Selected: 0
NCT IDTitle
NCT02525692Oral ONC201 in Adult Recurrent Glioblastoma
NCT05126433Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors
NCT02348593"Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy"
NCT06261450Effect of CBD on the Brain
NCT02332655Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
NCT00590915Erwinase Master Treatment Protocol
NCT01461915Phase 2 Study to Assess the Efficacy & Safety of Gemcitabine + Nab Paclitaxel With or Without Dociparstat in Metastatic Pancreatic Cancer Patients
NCT05392374Expanded Access Use of ONC201 in a Patient With Diffuse Intrinsic Pontine Gliomas
NCT02718755Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic Malignancies
NCT03954106A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity
NCT01485770A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness
NCT01886105Combination of External Beam Radiotherapy With 153Sm-EDTMP to Treat High Risk Osteosarcoma
NCT00675948Study to Compare the Safety and Tolerability of Sativex® in Patients With Cancer Related Pain
NCT00641186Trial of Xyrem for Excessive Daytime Sleepiness and Sleep Disturbance in Parkinson's Disease (PD)
NCT02348619"Six-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in OSA"
NCT02091375Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)
NCT02150928An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)
NCT00822094Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
NCT05024552Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML
NCT01606137A Study of the Long-term Safety of Sativex Use
NCT02167685The Chimerix CMX001 Registry
NCT07290985AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas
NCT03335267Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia
NCT02647190Intravenous Erwinia Chrysanthemi Asparaginase in Patients With Newly Diagnosed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Aged 60 Years or Older
NCT03825796CPX-351 Plus Enasidenib for Relapsed AML
NCT03436953A Phase 2 Study of CX-8998 in Adults With Tremor Associated With Parkinson's Disease
NCT07377539A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy Participants
NCT01323465Study to Evaluate the Effect of Rifampicin, Ketoconazole, and Omeprazole on the Pharmacokinetics of Sativex
NCT02348632"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"
NCT04231851CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia
NCT00711880A Study of Sativex® for Relief of Peripheral Neuropathic Pain Associated With Allodynia.
NCT03865589Using Ultrasound Elastography to Predict Development of Hepatic Sinusoidal Obstruction Syndrome
NCT02365610A Study of GWP42006 in People With Focal Seizures - Part B
NCT05558124CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
NCT01606176A Study to Evaluate the Effects of Cannabis Based Medicine in Patients With Pain of Neurological Origin
NCT03030599A Study of the Efficacy and Safety of JZP-258 in Subjects With Narcolepsy With Cataplexy
NCT00875693A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)
NCT02544763A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
NCT03416530ONC201 in Pediatric H3 K27M Gliomas
NCT03032016European VOD Registry
NCT00272948Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide
NCT04252586A Long-term Safety Study of Cannabidiol Oral Solution (GWP42003-P, CBD-OS) in Patients With Rett Syndrome
NCT05733390A Study of JZP541 in Adults With Irritability Associated With Autism Spectrum Disorder
NCT04732065ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
NCT02564952An Open-label Extension Study to Investigate Possible Drug-drug Interactions Between Clobazam and Cannabidiol
NCT05169307CPX-351 Real-World Effectiveness and Safety Study
NCT05557045A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein Kinase (MAPK) Pathway Alterations to Investigate the Safety, Dosing, and Antitumor Activity of JZP815
NCT04721691Efficacy of Epidiolex in Patients With Electrical Status Epilepticus of Sleep (ESES).
NCT06261502Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals with Fragile-X Syndrome
NCT03339401The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation